Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract.
antivirals
gold nanoparticles
measles
virucidal activity
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
30 11 2019
30 11 2019
Historique:
received:
29
10
2019
revised:
22
11
2019
accepted:
22
11
2019
entrez:
6
12
2019
pubmed:
6
12
2019
medline:
6
10
2020
Statut:
epublish
Résumé
Measles virus (MeV) is a paramyxovirus that infects humans, principally children. Despite the existence of an effective and safe vaccine, the number of cases of measles has increased due to lack of vaccination coverage. The World Health Organization (WHO) reports that the number of cases worldwide multiplied fourfold between January and March 2019, to 112,000. Today, there is no treatment available for MeV. In recent years, it has been demonstrated that natural extracts (herbal or algal) with antiviral activity can also work as reducing agents that, in combination with nanotechnology, offer an innovative option to counteract viral infections. Here, we synthetized and evaluated the antiviral activity of gold nanoparticles using garlic extract (
Identifiants
pubmed: 31801280
pii: v11121111
doi: 10.3390/v11121111
pmc: PMC6950311
pii:
doi:
Substances chimiques
Antiviral Agents
0
Plant Extracts
0
Gold
7440-57-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Control Release. 2009 Sep 15;138(3):197-204
pubmed: 19386272
Bioorg Med Chem Lett. 2010 May 1;20(9):2718-21
pubmed: 20382017
Int J Nanomedicine. 2018 May 31;13:3235-3250
pubmed: 29910612
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40
pubmed: 18003910
Viruses. 2018 Aug 30;10(9):
pubmed: 30200234
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Crit Rev Microbiol. 2016;42(1):46-56
pubmed: 24754250
Vaccine. 2014 Dec 5;32(51):6880-6883
pubmed: 25444814
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2641-6
pubmed: 16481622
Appl Microbiol Biotechnol. 2001 Oct;57(3):282-6
pubmed: 11759674
Antiviral Res. 2003 Mar;58(1):73-9
pubmed: 12719009
J Nanobiotechnology. 2010 Jan 20;8:1
pubmed: 20145735
Appl Microbiol Biotechnol. 2019 Jan;103(2):881-891
pubmed: 30413849
Biomed Res Int. 2016;2016:8502123
pubmed: 27419139
J Infect Dis. 2011 Jul;204 Suppl 1:S1-3
pubmed: 21666150
Cell Mol Biol (Noisy-le-grand). 2018 Jun 30;64(9):24-32
pubmed: 30030950
Clin Microbiol Rev. 2016 Jul;29(3):695-747
pubmed: 27281742
J Control Release. 2001 Jul 10;75(1-2):143-53
pubmed: 11451504
J Virol. 2009 Aug;83(16):7996-8003
pubmed: 19474104
Int J Nanomedicine. 2019 Aug 06;14:6217-6229
pubmed: 31496682
J Phys Chem B. 2006 Aug 17;110(32):15700-7
pubmed: 16898714
Nat Mater. 2018 Feb;17(2):195-203
pubmed: 29251725
J Microbiol Biotechnol. 2016 Jan;26(1):151-9
pubmed: 26403820
MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51
pubmed: 26562349